Core Viewpoint - Blue Arrow Aerospace, known as "China's SpaceX," experienced a failure in the flight test of its Zhuque-2 rocket, with the specific reasons for the failure currently under analysis [1][2]. Company Overview - Blue Arrow Aerospace has initiated guidance for an IPO on the Sci-Tech Innovation Board, aiming to become the first commercial aerospace company listed in this sector [6]. - The company is valued at 20 billion yuan and has completed two vertical landing recovery tests, being the first in the world to successfully place a liquid oxygen-methane rocket into orbit [7][9]. - Founded in 2015, Blue Arrow Aerospace is one of the earliest private commercial rocket companies in China, with its Zhuque-1 rocket launch in 2018 marking a significant milestone [9]. Financial Performance - Blue Arrow Aerospace reported net losses of 1.177 billion yuan and 1.015 billion yuan for 2023 and 2024, respectively [7]. - In April 2023, Country Garden announced the sale of approximately 11.063% of its shares in Blue Arrow Aerospace for a total of 1.305 billion yuan, indicating a strategic move to alleviate liquidity pressures [8]. Technological Achievements - The Zhuque-2 rocket is the first commercially operational liquid rocket in China, having undergone five flights, while the next-generation Zhuque-3 rocket is expected to achieve its maiden flight by 2025 [9]. - Blue Arrow Aerospace is recognized for its comprehensive capabilities in designing, manufacturing, testing, and launching liquid oxygen-methane rockets, making it the only private company in China to master key technologies in this area [7][9].
火箭飞行试验任务失利,“中国版Space X”蓝箭航天道歉!公司估值200亿元,已启动IPO辅导
Mei Ri Jing Ji Xin Wen·2025-08-15 15:11